• If you are wondering whether Ardent Health's current share price reflects its real worth, this article will walk you through what the numbers are saying about value.
• The stock last closed at US$8.58, with a 4.1% return over the past 7 days, a 7.9% decline over the last 30 days, and a 0.7% decline year to date, compared with a 42.3% decline over the past year.
• Recent news flow around Ardent Health has largely centered on its position within the US healthcare sector and how investors are assessing hospital operators in the current market. These headlines help set the backdrop for why short term moves can look very different to the longer term return picture.
• On our valuation checklist Ardent Health scores 4/6 for being undervalued. Next, we will look at how different valuation methods arrive at that score before finishing with a way to assess value that goes beyond the usual metrics.

Approach 1: Ardent Health Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a business might be worth today by projecting its future cash flows and then discounting those back to a present value.

For Ardent Health, the model used is a 2 Stage Free Cash Flow to Equity approach based on cash flow projections in $. The company’s latest twelve month free cash flow is about $179.6 million. Analysts provide explicit forecasts up to 2027, including a projected free cash flow of $64.0 million in 2027, and Simply Wall St extrapolates the remaining years out to 2035 using the pattern implied by those estimates.

When these projected cash flows are discounted back, the DCF output suggests an estimated intrinsic value of about $4.68 per share. Compared with the recent share price of $8.58, this implies the stock is trading at roughly a 83.2% premium to the model’s estimate, which points to Ardent Health screening as expensive on this DCF view.

Result: OVERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Ardent Health may be overvalued by 83.2%. Discover 55 high quality undervalued stocks or create your own screener to find better value opportunities.

Approach 2: Ardent Health Price vs Earnings

P/E is a useful yardstick for a profitable company like Ardent Health because it links what you pay for each share directly to the earnings that business is currently generating. Investors typically accept a higher P/E when they expect stronger earnings growth or see lower risk in those earnings, and a lower P/E when growth expectations are modest or risks are higher.

Ardent Health currently trades on a P/E of about 6.0x. That sits well below the Healthcare industry average P/E of about 23.2x and also below the peer average of about 23.0x. At face value, this points to a lower market valuation compared with many listed hospital and healthcare operators.

Simply Wall St’s Fair Ratio for Ardent Health is 16.58x. This is a proprietary estimate of what a “normal” P/E could look like for the company given its earnings growth profile, industry, profit margins, market cap and specific risks. Because it tries to match the multiple to the company’s own characteristics rather than broad peer groups, it can often be more tailored than simple industry or peer comparisons. With the current P/E at 6.0x and the Fair Ratio at 16.58x, Ardent Health screens as undervalued on this measure.

Result: UNDERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 22 top founder-led companies.

Upgrade Your Decision Making: Choose your Ardent Health Narrative

Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives, which are simply your story about a company linked directly to your own assumptions for fair value, future revenue, earnings and margins.

On Simply Wall St, Narratives live in the Community page and let you connect Ardent Health’s story to a financial forecast and then to a fair value, so you can quickly compare that fair value to the current share price and decide whether the stock looks attractive or not based on your view.

Because Narratives on the platform are updated when fresh information arrives, such as new earnings or meaningful news, your story and valuation can stay aligned with what is actually happening rather than staying locked to a static model.

For example, one Ardent Health Narrative might centre on tight cost control and steady margins that support a higher fair value, while another could assume more muted profitability and assign a lower fair value, giving you a clear sense of where your own view sits along that spectrum.

Do you think there's more to the story for Ardent Health? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.